首页> 外文期刊>Indian Journal of Ophthalmology >Eyelid retraction discomfort with cotton-tipped applicator, unimanual and speculum intravitreal injection techniques: Eyelid retraction technique randomized comparison trial (Eyelid RETRACT)
【24h】

Eyelid retraction discomfort with cotton-tipped applicator, unimanual and speculum intravitreal injection techniques: Eyelid retraction technique randomized comparison trial (Eyelid RETRACT)

机译:眼睑缩回与棉花涂抹器的不适,单身涂层玻璃体涂层技术:眼睑收缩技术随机化比较试验(眼睑缩回)

获取原文
           

摘要

Purpose: The aim of this study was to test the discomfort experienced during intravitreal injections with eyelid retraction between an eyelid speculum, cotton-tipped applicator (CTA), and unimanual eyelid retraction techniques. Methods: In total, 99 patients receiving intravitreal bevacizumab were enrolled into this prospective study. Participants were randomized to one of the three methods, given subconjunctival 2% lidocaine and then injected in the superior temporal quadrant. Immediately after the procedure, each patient was given a visual analog scale (VAS) to rate their discomfort. Results: The mean pain scores for eyelid retraction with unimanual, CTA, and speculum groups were 0.788 (standard deviation [SD] 0.70, 95% confidence interval [CI] 0.448–1.128), 0.945 (SD 1.28, 95% CI 0.600–1.291), and 1.561 (SD 1.28, 95% CI 1.210–1.912), respectively. A one-way analysis of variance (ANOVA) test revealed a significant difference between the groups (P = 0.006). Post hoc analysis also revealed a difference in mean pain scores between the speculum and both the CTA and the unimanual methods. Conclusion: Our study shows that the unimanual and CTA methods for eyelid retraction are significantly less painful for patients compared to the speculum method. Patient comfort is of the utmost importance as intravitreal injections are performed millions of times a year with most patients requiring multiple injections.
机译:目的:本研究的目的是测试在眼睑窥器,棉花涂布器(CTA)和不可移动的眼睑收缩技术之间的眼睑缩回时玻璃体质注射过程中经历的不适。方法:总共有99例接受玻璃体内贝伐单抗的患者纳入了这项前瞻性研究。参与者被随机化为三种方法之一,给予亚细胞2%利多卡因,然后在上颞象限中注射。在手术后立即,每位患者被赋予视觉模拟量表(VAS)以评估它们的不适。结果:对单眼,CTA和窥器基团进行眼睑缩小的平均疼痛评分为0.788(标准偏差[SD] 0.70,95%置信区间[CI] 0.448-1.128),0.945(SD 1.28,95%CI 0.600-1.291 )和1.561(SD 1.28,95%CI 1.210-1.912)。方差单向分析(ANOVA)测试显示,组之间的显着差异(p = 0.006)。后HOC分析还揭示了窥器和CTA和单一的均衡方法之间平均疼痛评分的差异。结论:我们的研究表明,与窥器方法相比,对患者的眼睑缩回不那么痛苦的痛苦显着不那么痛苦。由于大多数需要多次注射的患者,患者患者舒适性是最重要的,因为玻璃体内注射每年进行数百万次次数。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号